Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001209191-22-019403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | AXSM | Coleman Mark | Dir | M - OptEx | $1.30 | +3,496 | 7,596 | +85% | +$4,545 |
| D | 2022-03-17 | 2022-03-15 | AXSM | Coleman Mark | Dir | M - OptEx | $0.00 | -3,496 | 17.5K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | M | A | 3,496 | $1.30 | 7,596 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-03-15 | M | D | 3,496 | $0.00 | 17,501 | D | $1.30 · 2013-03-22 to 2023-03-21 | 3,496 Common Stock |